Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 12455 [2017-04102]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices
affiliation, mailing address, telephone
number, email address).
• Letter(s) of recommendation from
person(s) not employed by the U.S.
Department of Health and Human
Services.
Contact Person for More Information:
Nancy Anderson, Chief, Laboratory
Practice Standards Branch, Division of
Laboratory Systems, Center for
Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE., Mailstop F–11,
Atlanta, Georgia 30329–4018; telephone
(404) 498–2741; or via email at
NAnderson@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Cooperative Research Agreements to
the World Trade Center Health Program
(U01)’’, PAR 16–098.
Contact Person for More Information:
Nina Turner, Ph.D., Scientific Review
Officer, CDC/NIOSH, 1095 Willowdale
Road, Mailstop G905, Morgantown,
West Virginia 26505, Telephone: (304)
285–5975.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–04102 Filed 3–2–17; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2017–04103 Filed 3–2–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), PAR 16–098 Cooperative
Research Agreements to the World
Trade Center Health Program (U01).
Times and Dates:
8:00 a.m.–5:00 p.m., EDT, March 28,
2017 (Closed)
8:00 a.m.–12:00 p.m., EDT, March 29,
2017(Closed)
Place: Courtyard Marriott Decatur
Downtown/Emory, 130 Clairemont
Avenue, Decatur, Georgia 30030,
Telephone: (404)371–0204.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
VerDate Sep<11>2014
16:42 Mar 02, 2017
Jkt 241001
Request for Nominations of
Candidates To Serve on the Mine
Safety and Health Research Advisory
Committee (MSHRAC), National
Institute for Occupational Safety and
Health, Centers for Disease Control
and Prevention (CDC), Department of
Health and Human Services
The CDC is soliciting nominations for
possible membership on the Mine
Safety and Health Research Advisory
Committee (MSHRAC), National
Institute for Occupational Safety and
Health (NIOSH).
The MSHRAC consists of 13 experts
in fields related to mining safety and
health. The members are selected by the
Secretary of the U.S. Department of
Health and Human Services (HHS). The
committee advises the NIOSH Director
on mining safety and health research
and prevention programs. The
committee also provides advice on
standards of scientific excellence,
current needs in the field of mining
safety and health, and the applicability
and dissemination of research findings.
This advice may take the form of reports
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
12455
or verbal communications to the NIOSH
Director during MSHRAC meetings.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the committee’s
mission.
Nominees will be selected based on
expertise in the field of mining safety
and health, such as mining engineering,
industrial hygiene, occupational safety
and health engineering, chemistry,
safety and health education,
ergonomics, epidemiology, statistics,
and psychology. Members may be
invited to serve for terms of up to four
years.
The U.S. Department of Health and
Human Services policy stipulates that
Committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for the MSHRAC membership each year,
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, email address)
• A letter of recommendation stating
the qualifications of the candidate.
Nomination materials must be
postmarked by April 30, 2017, and sent
to: Jeffrey H. Welsh, Designated Federal
Officer for MSHRAC, NIOSH, CDC, 626
Cochrans Mill Road, Pittsburgh, PA
15236, telephone (412) 386–4040.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for the Centers
for Disease Control and Prevention and
E:\FR\FM\03MRN1.SGM
03MRN1
]]>Agencies
[Federal Register Volume 82, Number 41 (Friday, March 3, 2017)]
[Notices]
[Page 12455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04102]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA), PAR
16-098 Cooperative Research Agreements to the World Trade Center Health
Program (U01).
Times and Dates:
8:00 a.m.-5:00 p.m., EDT, March 28, 2017 (Closed)
8:00 a.m.-12:00 p.m., EDT, March 29, 2017(Closed)
Place: Courtyard Marriott Decatur Downtown/Emory, 130 Clairemont
Avenue, Decatur, Georgia 30030, Telephone: (404)371-0204.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Cooperative Research Agreements to the World Trade Center Health
Program (U01)'', PAR 16-098.
Contact Person for More Information: Nina Turner, Ph.D., Scientific
Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905,
Morgantown, West Virginia 26505, Telephone: (304) 285-5975.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-04102 Filed 3-2-17; 8:45 am]
BILLING CODE 4163-18-P
